Sanofi provides education and resources on early screening for Type 1 diabetes, empowering healthcare providers to identify at-risk patients before clinical symptoms appear. Through autoantibody testing, physicians can detect early-stage Type 1 diabetes, enabling timely monitoring, patient education, and access to care pathways that can delay disease progression. To learn more about screening resources and how to identify patients who may benefit from testing, visit our exhibit.